ab32010 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab32010 は 20 報の論文で使用されています。

  • Harrison DJ  et al. The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse. Cell Transplant 27:230-244 (2018). PubMed: 29637815
  • Mendoza E & Scharff C Protein-Protein Interaction Among the FoxP Family Members and their Regulation of Two Target Genes, VLDLR and CNTNAP2 in the Zebra Finch Song System. Front Mol Neurosci 10:112 (2017). WB . PubMed: 28507505
  • Lu TX  et al. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep 5:12168 (2015). IHC ; Human . PubMed: 26202875
  • Xu Y  et al. Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma. J Cancer 6:953-61 (2015). PubMed: 26316891
  • Rouhigharabaei L  et al. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1. PLoS One 9:e85851 (2014). WB ; Human . PubMed: 24416450
  • Luxey M  et al. Eph:ephrin-B1 forward signaling controls fasciculation of sensory and motor axons. Dev Biol 383:264-74 (2013). PubMed: 24056079
  • Zhang Y  et al. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. J Clin Pathol 65:528-33 (2012). IHC-Fr ; Human . PubMed: 22422806
  • Feng J  et al. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer. Am J Clin Pathol 138:230-5 (2012). Human . PubMed: 22904134
  • Sebestyén A  et al. Activity and complexes of mTOR in diffuse large B-cell lymphomas-a tissue microarray study. Mod Pathol : (2012). PubMed: 22899290
  • Coffinier C  et al. Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc Natl Acad Sci U S A 107:5076-81 (2010). IHC-Fr ; Mouse . PubMed: 20145110
  • Brown PJ  et al. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood 111:2816-24 (2008). PubMed: 18077790
  • Giatromanolaki A  et al. Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression. Mod Pathol 19:9-16 (2006). PubMed: 16258506
  • Haralambieva E  et al. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 20:1300-3 (2006). PubMed: 16673020
  • Sagaert X  et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol 24:2490-7 (2006). PubMed: 16636337
  • Brown P  et al. The FOXP1 Transcription Factor is Expressed in the Majority of Follicular Lymphomas but is Rarely Expressed in Classical and Lymphocyte Predominant Hodgkin's Lymphoma. J Mol Histol 36:249-56 (2005). PubMed: 16200457
  • Banham AH  et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res 11:1065-72 (2005). PubMed: 15709173
  • Barrans SL  et al. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 104:2933-5 (2004). PubMed: 15238418
  • Fox SB  et al. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas. Clin Cancer Res 10:3521-7 (2004). PubMed: 15161711
  • Hans CP  et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-82 (2004). PubMed: 14504078
  • Banham AH  et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 61:8820-9 (2001). PubMed: 11751404